Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102050775A details a novel method for synthesizing and isolating a critical succinimide-based impurity of Anastrozole, ensuring robust quality control and supply chain reliability for API manufacturers.
Discover a high-yield Melphalan synthesis route using L-phenylalanine. Optimized for cost reduction in pharmaceutical manufacturing with superior impurity control.
Novel low-palladium Heck cyclization route for 6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. Reduces cost and waste.
Novel chiral catalytic hydrogenation route for Duvelisib reduces steps and improves safety for reliable API intermediate supply.
Patent CN103864877A reveals a high-yield Suzuki coupling route for Abiraterone Acetate, offering significant cost reduction and greener manufacturing for pharmaceutical intermediates.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Explore CN1108653A technology for synthesizing hyper-potent paclitaxel analogs. Offers superior solubility and antitumor activity for reliable API intermediate supply chains.
Novel green route for Sonidegib intermediates via epoxide ring-opening. Eliminates expensive chiral starting materials and reduces wastewater for cost-effective manufacturing.
Novel industrial method for Dasatinib synthesis avoiding palladium catalysts, offering cost reduction and scalable production for pharmaceutical manufacturers.
Discover a novel 3-step synthesis for Lenalidomide intermediates using glutarimide. Achieve high purity and significant cost reduction in pharma manufacturing with scalable routes.
Patent CN114230568B details a high-yield 4-step route for HER2 inhibitor Tucatinib using Pd(acac)2, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Advanced chiral resolution technology for Crizotinib intermediates ensures high purity and cost reduction in API manufacturing for global supply chains.
Discover a novel mild process for Capecitabine synthesis from Furtulon. High purity, scalable route offering significant cost reduction in pharmaceutical manufacturing.
Patent CN109096148B reveals a novel one-pot method for Vorinostat using modified mesoporous silica, offering high purity and simplified supply chain for pharmaceutical manufacturers.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Patent CN113651800A reveals a high-yield route for Oxitinib Mesylate, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103601777A details a high-purity capecitabine preparation method using isopropyl ether crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112979723B details a novel Schiff base purification strategy for Gemcitabine intermediates, ensuring superior purity and yield for pharmaceutical manufacturing.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.